Facebook
X
LinkedIn
Forward
VIRTUAL REGISTRATION: 51st Annual Psychopharmacology Conference
We invite you to join us Virtually for our 51st Annual Psychopharmacology Conference!
NOTE: Thursday ticketed events and Friday and Saturday evening seminars are NOT included in the virtual registration option. These sessions will NOT be live-streamed.
Engage with Experts.
Elevate Results.
Enhance your Practice.
Please Note: The conference will be held in Eastern (EDT)
Celebrating 51 Years of Advancing Psychiatric Medicine
We invite you to attend the 51st Annual Psychopharmacology Conference virtually! This conference marks a meaningful milestone in the evolution of psychiatric education and care.
For over five decades, this event has brought together leading experts and dedicated clinicians to advance the understanding and treatment of mental health conditions.
What You Can Expect
This year’s program continues our commitment to clinical depth, scientific rigor, and practical application. Topics include:
Depression, Bipolar Disorder, and Anxiety
Psychosis and OCD
ADHD and PTSD
Substance Use Disorders
Integrative Approaches and Pharmacologic Innovations
Every session is designed to help you stay current on emerging research, examine evolving standards of care, and apply evidence-based strategies to complex clinical situations.
You will receive email communication (to the email registered to your MGH Psychiatry Academy account) as we get closer to the conference date with details on the Zoom instructions and attending virtually.
Pricing
MDs/Doctoral-Level Professionals:
Early Bird Registration (on or before August 15, 2027): $950.00
Regular Registration (after August 15, 2027): $1085.00
Other Professionals or Trainees:
Early Bird Registration (on or before August 15, 2027): $750.00
Regular Registration (after August 15, 2027): $850.00
Live Registration:
The conference occurs live at the Westin Copley Place in Boston. For more information about in-person attendance and the venue, please visit our live registration page:
Psychopharmacology 2027: Live Registration - Click Here
E-Syllabus
We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference.
Cancellation Policy
No refunds will be issued for refund requests. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.
Massachusetts General Hospital Psychiatry Update & Board Preparation, 4th Edition
Board certification and recertification exams are critical career moments. That is why you should rely on the Massachusetts General Hospital Psychiatry Update & Board Preparation, Fourth Edition. It puts our 80+ years of clinical experience at your fingertips to help you prepare for your exam.
Purchase a print copy of our Board Preparation book here!
MOC Self-Assessment Module: Psychopharmacology
As part of recertification requirements, physicians must participate in Maintenance of Certification Program (MOC) activities like this one to cultivate a focus on lifelong learning and competency throughout one’s profession. This module helps you hone in on clinical and practice management skills that are central to quality patient care and improved outcomes for patients.
Target Audience
This program is intended for psychiatrists, psychologists, general and family practice physicians, psychiatric nurses, physician assistants, nurse practitioners, and social workers.
Learning Objectives
Accreditation and Learning Objectives Pending: Please check back for more information.
Course summary
51st ANNUAL PSYCHOPHARMACOLOGY
OCTOBER 21-24, 2027
WESTIN COPLEY PLACE
BOSTON
Please check back for Program information.
Policy on Faculty and Provider Disclosure:
Disclosure Information
In accordance with the disclosure policy of MGH Institute of Health Professions as well as guidelines set forth by the Accreditation Council on Continuing Medical Education, all people in control of educational content, including speakers, course directors, planners, and reviewers, have been asked to disclose all financial relationships with ineligible companies for the past 24 months, as defined below:
Ineligible Companies
The ACCME defines an “Ineligible company” as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” For more information, visit accme.org/standards.
Financial Relationships
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
Mitigation of Financial Relationships
All financial relationships are reviewed to determine which ones are relevant, and then measures are taken to mitigate all relevant financial relationships and ensure that they do not insert commercial bias into the content of the education.
Faculty
Course Directors:
Maurizio Fava, MD
Chair, Mass General Brigham Academic Medical Centers (AMC) Department of Psychiatry
Co-Chair, Mass General Brigham Research Oversight Committee (ROC)
Executive Director, Clinical Trials Network and Institute (CTNI)
Mass General Brigham (MGB)
Slater Family Professor of Psychiatry
Harvard Medical School
Jerrold F. Rosenbaum, MD
Psychiatrist-in-Chief Emeritus
Director, Center for the Neuroscience of Psychedelics
Massachusetts General Hospital
Stanley Cobb, Professor of Psychiatry, Harvard Medical School